Inventor · disambiguated record
Lianne Smith
Also filed as: SMITH LIANNE
12 granted patents·3 pending applications·111 citations·filing 2014–2025
90Inventor score
Top patents by PatentIndex Score
15 records- 0197US9181321B2CFTR mRNA compositions and related methods and usesSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Nov 10, 2015·50 cites·18 claims
- 0296US9713626B2CFTR mRNA compositions and related methods and usesSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Jul 25, 2017·23 cites·19 claims
- 0395US10646504B2Synergistic enhancement of the delivery of nucleic acids via blended formulationsTRANSLATE BIO INC·Filed 2018·Granted May 12, 2020·8 cites·14 claims
- 0495US10130649B2Synergistic enhancement of the delivery of nucleic acids via blended formulationsTRANSLATE BIO INC·Filed 2014·Granted Nov 20, 2018·15 cites·14 claims
- 0591US10835583B2Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiencyTRANSLATE BIO INC·Filed 2017·Granted Nov 17, 2020·4 cites·18 claims
- 0689US11167043B2Composition and methods for treatment of ornithine transcarbamylase deficiencyTRANSLATE BIO INC·Filed 2018·Granted Nov 9, 2021·4 cites·4 claims
- 0786US12201677B2Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiencyTRANSLATE BIO INC·Filed 2020·Granted Jan 21, 2025·1 cites·24 claims
- 0886US11510937B2CFTR MRNA compositions and related methods and usesTRANSLATE BIO INC·Filed 2019·Granted Nov 29, 2022·1 cites·13 claims
- 0985US11224642B2MRNA therapy for argininosuccinate synthetase deficiencyTRANSLATE BIO INC·Filed 2014·Granted Jan 18, 2022·3 cites·16 claims
- 1082US10420791B2CFTR MRNA compositions and related methods and usesTRANSLATE BIO INC·Filed 2017·Granted Sep 24, 2019·2 cites·13 claims
- 1172US12268754B2Composition and methods for treatment of ornithine transcarbamylase deficiencyTRANSLATE BIO INC·Filed 2021·Granted Apr 8, 2025·0 cites·18 claims
- 1267US12453739B2Synergistic enhancement of the delivery of nucleic acids via blended formulationsTRANSLATE BIO INC·Filed 2020·Granted Oct 28, 2025·0 cites·20 claims
- 1364US2025152739A1Composition and methods for treatment of ornithine transcarbamylase deficiencyTRANSLATE BIO INC·Filed 2025·Application pending·0 cites
- 1463US2016122727A1Messenger rna based viral productionSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Application pending·0 cites
- 1559US2019127708A1Messenger rna based viral productionTRANSLATE BIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lianne Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →